(Q51584281)

English

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).

scientific article published on 29 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Xiaoye Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pim J van Leeuwen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Meelan Bul

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Chris H Bangma

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Fritz H Schröder

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

0 references

publication date

29 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2847-2854

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Under diagnosis and over diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

The story of the European Randomized Study of Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

High-risk prostate cancer in the United States, 1990-2007

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Mammographic screening and disease presentation of breast cancer patients who die of disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Adjuvant radiotherapy after radical prostatectomy: indications, results and side effects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51584281&oldid=1237368676"